Copyright
©The Author(s) 2022.
World J Clin Oncol. Sep 24, 2022; 13(9): 748-757
Published online Sep 24, 2022. doi: 10.5306/wjco.v13.i9.748
Published online Sep 24, 2022. doi: 10.5306/wjco.v13.i9.748
Figure 1 A flowchart of eligible patients.
PET/CT: Positron emission tomography/computed tomography.
Figure 2 Correlation between the maximal diameter of metastasis in the sentinel lymph nodes and number of axillary lymph node metastases.
A strong correlation is evident between maximal diameter of metastasis in the sentinel lymph nodes and the number of axillary lymph node metastases (P < 0.001). ALMNs: Axillary lymph node metastases.
Figure 3 Cut-off value for the maximal diameter of metastasis in the sentinel lymph node from the receiver operating characteristic curve and cut-off for upstaging from N0 to pN2a/pN3a set to 5 mm (area under the curve: 0.
873, 95%CI: 0.808-0931).
- Citation: Oda G, Nakagawa T, Mori H, Onishi I, Fujioka T, Mori M, Kubota K, Hanazawa R, Hirakawa A, Ishikawa T, Okamoto K, Uetakesszsz H. Factors predicting upstaging from clinical N0 to pN2a/N3a in breast cancer patients. World J Clin Oncol 2022; 13(9): 748-757
- URL: https://www.wjgnet.com/2218-4333/full/v13/i9/748.htm
- DOI: https://dx.doi.org/10.5306/wjco.v13.i9.748